Literature DB >> 10226069

alpha4 integrin-dependent eotaxin induction of bronchial hyperresponsiveness and eosinophil migration in interleukin-5 transgenic mice.

T Hisada1, P G Hellewell, M M Teixeira, M G Malm, M Salmon, T J Huang, K F Chung.   

Abstract

We investigated the roles of eosinophil infiltration and activation induced by the eosinophil-selective chemokine eotaxin, and of the expression of eosinophil alpha4 and beta2 integrins in causing bronchial hyperresponsiveness (BHR) in interleukin (IL)-5 CBA/Ca transgenic mice. These mice did not show BHR, despite the presence of some eosinophils in the lungs. Intratracheal mouse recombinant eotaxin (3 micrograms) did not induce BHR in wild-type mice. In IL-5 transgenic mice, eotaxin (3 and 5 micrograms) increased responsiveness at 24 h and increased eosinophils in bronchoalveolar lavage (BAL) fluid by 9.4- and 14-fold by 24 h, respectively, together with augmentation of eosinophil peroxidase activity and eosinophil infiltration in the airway submucosa. Using flow cytometry, the expression of alpha4, CD11b, and CD18 was upregulated in BAL, but not in blood, eosinophils. A rat anti-alpha4 antibody inhibited eotaxin-induced BHR and eosinophil migration and activation, but an anti-CD11b antibody had no significant effects on BHR. A combination of both antibodies was more effective. IL-5 and eotaxin synergize in the induction of BHR and airway eosinophilia, effects that are dependent on the induction of eosinophil alpha4 integrin. Expression of BHR depends on the recruitment and activation of eosinophils.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10226069     DOI: 10.1165/ajrcmb.20.5.3473

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  9 in total

Review 1.  Pathophysiological mechanisms of asthma. Application of cell and molecular biology techniques.

Authors:  K F Chung; I M Adcock
Journal:  Mol Biotechnol       Date:  2001-07       Impact factor: 2.695

2.  Evidence for systemic rather than pulmonary effects of interleukin-5 administration in asthma.

Authors:  E L van Rensen; R G Stirling; J Scheerens; K Staples; P J Sterk; P J Barnes; K F Chung
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

3.  Dissection of the hyperadhesive phenotype of airway eosinophils in asthma.

Authors:  Steven R Barthel; Nizar N Jarjour; Deane F Mosher; Mats W Johansson
Journal:  Am J Respir Cell Mol Biol       Date:  2006-04-06       Impact factor: 6.914

4.  Nonhematopoietic NADPH oxidase regulation of lung eosinophilia and airway hyperresponsiveness in experimentally induced asthma.

Authors:  Hiam Abdala-Valencia; Julie Earwood; Shelly Bansal; Michael Jansen; George Babcock; Beth Garvy; Marsha Wills-Karp; Joan M Cook-Mills
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-02-09       Impact factor: 5.464

5.  Failure of sputum eosinophilia after eotaxin inhalation in asthma.

Authors:  D Bumbacea; J Scheerens; B S Mann; R G Stirling; K F Chung
Journal:  Thorax       Date:  2004-05       Impact factor: 9.139

6.  Chemotaxis of bone marrow derived eosinophils in vivo: a novel method to explore receptor-dependent trafficking in the mouse.

Authors:  Eva M Sturm; Kimberly D Dyer; Caroline M Percopo; Akos Heinemann; Helene F Rosenberg
Journal:  Eur J Immunol       Date:  2013-06-14       Impact factor: 5.532

Review 7.  Roles of integrin activation in eosinophil function and the eosinophilic inflammation of asthma.

Authors:  Steven R Barthel; Mats W Johansson; Dawn M McNamee; Deane F Mosher
Journal:  J Leukoc Biol       Date:  2007-10-10       Impact factor: 4.962

8.  A novel transcription factor inhibitor, SP100030, inhibits cytokine gene expression, but not airway eosinophilia or hyperresponsiveness in sensitized and allergen-exposed rat.

Authors:  T J Huang; I M Adcock; K F Chung
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 9.473

9.  Protective Role of Proton-Sensing TDAG8 in Lipopolysaccharide-Induced Acute Lung Injury.

Authors:  Hiroaki Tsurumaki; Chihiro Mogi; Haruka Aoki-Saito; Masayuki Tobo; Yosuke Kamide; Masakiyo Yatomi; Koichi Sato; Kunio Dobashi; Tamotsu Ishizuka; Takeshi Hisada; Masanobu Yamada; Fumikazu Okajima
Journal:  Int J Mol Sci       Date:  2015-12-04       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.